AI assistant
Sending…
ArcticZymes Technologies — Director's Dealing 2015
Mar 29, 2015
3538_dirs_2015-03-29_20467cfb-cc4f-4590-80c1-e270b851284d.html
Director's Dealing
Open in viewerOpens in your device viewer
Primærinnsidermelding
Primærinnsidermelding
Ansattvalgt styremedlem Gerd Nilsen har solgt 11.056 aksjer i
Biotec Pharmacon den 27.mars 2015 til kurs 18,10 per aksje
Gerd Nilsen har 0 (null) Biotec Pharmacon aksjer igjen etter salget
More from ArcticZymes Technologies
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report (ESEF)
2026
Apr 30
Regulatory Filings
2026
Apr 30